: Here we focus on people with advanced PD undergoing percutaneous endoscopic transgastric jejunostomy (PEG-J) ("one stone") for LCIG infusion therapy for managing severe motor fluctuations ("first bird") and discuss its implications for improving accompanying symptoms of cardiovascular, urinary, and gastrointestinal autonomic failure ("second bird").

Levodopa/carbidopa intestinal gel via percutaneous endoscopic transgastric jejunostomy in advanced Parkinson's disease: hitting two birds with one stone? / Rinaldi, Domiziana; Galli, Silvia; Fanciulli, Alessandra; Pontieri, Francesco E.. - In: PARKINSONISM & RELATED DISORDERS. - ISSN 1873-5126. - (2023), p. 105394. [10.1016/j.parkreldis.2023.105394]

Levodopa/carbidopa intestinal gel via percutaneous endoscopic transgastric jejunostomy in advanced Parkinson's disease: hitting two birds with one stone?

Domiziana Rinaldi
Primo
;
Silvia Galli
Secondo
;
Alessandra Fanciulli
Penultimo
;
Francesco E. Pontieri
Ultimo
2023

Abstract

: Here we focus on people with advanced PD undergoing percutaneous endoscopic transgastric jejunostomy (PEG-J) ("one stone") for LCIG infusion therapy for managing severe motor fluctuations ("first bird") and discuss its implications for improving accompanying symptoms of cardiovascular, urinary, and gastrointestinal autonomic failure ("second bird").
2023
Advanced Parkinson's disease; Constipation; Levodopa-carbidopa intestinal gel (LCIG); Nocturia; Orthostatic hypotension; Percutaneous endoscopic transgastric jejunostomy (PEG-J)
01 Pubblicazione su rivista::01a Articolo in rivista
Levodopa/carbidopa intestinal gel via percutaneous endoscopic transgastric jejunostomy in advanced Parkinson's disease: hitting two birds with one stone? / Rinaldi, Domiziana; Galli, Silvia; Fanciulli, Alessandra; Pontieri, Francesco E.. - In: PARKINSONISM & RELATED DISORDERS. - ISSN 1873-5126. - (2023), p. 105394. [10.1016/j.parkreldis.2023.105394]
File allegati a questo prodotto
File Dimensione Formato  
Rinaldi2023_GALLI_FANCIULLI_PONTIERI.pdf

solo gestori archivio

Note: Rinaldi_Levodopa/carbidopa intestinal gel_2023
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 398.51 kB
Formato Adobe PDF
398.51 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1680397
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact